Huda Suliman is President at Icaria Life Sciences. She spoke at the Ending Age-Related Diseases 2019, discussing her company’s role in the rejuvenation biotechnology ecosystem, including small molecule drug discovery and drug screening along with how her company deals with irreproducibility in the scientific literature. She explained how species differences are an issue, and she explained the differences between aging-focused and traditional medical research.